Nebizar-H Tablet
By Nebizar-H
Rx
10 Tablet in a Strip

Composition
Hydrochlorothiazide(12.5mg) + Nebivolol(5mg)

Manufacturer - Spectra Therapeutics Pvt Ltd
F-11, F-12, F-13, 1st FLOOR, NARAYAN KRUPA COMPLEX NEAR LALGEBI ASHRAM, GHUMA AHMEDABAD GJ 380058 IN , - , .

Expires on or after
July, 2026

liver
When using Nebizar-H Tablet, it is important to be cautious if you have liver disease. Patients with liver impairment should consult their doctor before taking this medication, as dose adjustment may be necessary. If you have any concerns about your liver health or if you are unsure about using Nebizar-H Tablet due to liver issues, it is recommended to seek advice from your healthcare provider for proper guidance.

kidney
Nebizar-H Tablet may require dose adjustment for patients with severe kidney disease. It is not recommended for those with severe kidney disease. Use with caution and consult your doctor regarding any kidney impairment concerns.

alcohol
Caution is advised when consuming alcohol with Nebizar-H Tablet because it may cause increased dizziness and lower blood pressure. Avoid alcohol while taking this medication to prevent side effects.

driving
"Nebizar-H Tablet may reduce alertness, impact vision, or induce drowsiness and dizziness. Avoid driving if experiencing these effects."

pregnancy
Nebizar-H Tablet may not be safe to use during pregnancy. Animal studies suggest potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor if you have concerns.

breastfeeding
Nebizar-H Tablet is likely unsafe during breastfeeding. Limited data indicates that it may pass into breastmilk and harm the baby. Avoid using Nebizar-H Tablet while breastfeeding. Consult your doctor for concerns.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹99
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024